ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,242,000 | -65.8% | 13,030 | -75.1% | 0.02% | -62.5% |
| Q2 2021 | $6,562,000 | -67.5% | 52,294 | -64.9% | 0.05% | -68.6% |
| Q1 2021 | $20,194,000 | -28.1% | 148,912 | -32.2% | 0.15% | -26.4% |
| Q4 2020 | $28,093,000 | +77.0% | 219,581 | +55.7% | 0.21% | +49.6% |
| Q3 2020 | $15,868,000 | +330.1% | 141,012 | +264.1% | 0.14% | +321.2% |
| Q2 2020 | $3,689,000 | +5.9% | 38,724 | -0.1% | 0.03% | -15.4% |
| Q1 2020 | $3,485,000 | – | 38,775 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |